Cinctive Capital Management LP Sells 12,282 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Cinctive Capital Management LP decreased its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 31.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,195 shares of the medical instruments supplier's stock after selling 12,282 shares during the quarter. Cinctive Capital Management LP owned approximately 0.11% of ICU Medical worth $4,773,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the stock. Point72 Hong Kong Ltd bought a new position in ICU Medical in the 3rd quarter valued at $72,000. Captrust Financial Advisors raised its holdings in shares of ICU Medical by 54.2% in the third quarter. Captrust Financial Advisors now owns 2,969 shares of the medical instruments supplier's stock valued at $541,000 after buying an additional 1,043 shares during the last quarter. Martingale Asset Management L P acquired a new position in ICU Medical during the 3rd quarter worth about $255,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in ICU Medical by 4.3% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 42,742 shares of the medical instruments supplier's stock worth $7,788,000 after acquiring an additional 1,751 shares during the last quarter. Finally, Public Sector Pension Investment Board grew its stake in shares of ICU Medical by 15.1% during the third quarter. Public Sector Pension Investment Board now owns 51,854 shares of the medical instruments supplier's stock valued at $9,449,000 after purchasing an additional 6,800 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on ICUI shares. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. Jefferies Financial Group began coverage on ICU Medical in a research report on Monday, October 14th. They issued a "hold" rating and a $183.00 price target on the stock. StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, November 20th. KeyCorp raised their target price on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a report on Wednesday, November 13th. Finally, Raymond James upped their price target on ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research note on Thursday, September 12th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $173.00.

ICU Medical Stock Down 2.9 %

ICUI traded down $4.73 during trading on Tuesday, reaching $156.23. The company had a trading volume of 127,412 shares, compared to its average volume of 273,324. The business's fifty day moving average price is $174.32 and its 200 day moving average price is $148.06. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 12 month low of $83.26 and a 12 month high of $196.26. The company has a market cap of $3.82 billion, a P/E ratio of -35.22 and a beta of 0.62.

Insider Buying and Selling at ICU Medical

In other news, CEO Vivek Jain sold 12,000 shares of the stock in a transaction dated Friday, November 1st. The shares were sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at $17,973,261.12. This represents a 10.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Christian B. Voigtlander sold 1,962 shares of the company's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $169.08, for a total value of $331,734.96. The disclosure for this sale can be found here. Insiders have sold 40,364 shares of company stock valued at $6,869,878 in the last 90 days. 6.70% of the stock is currently owned by company insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.